Home›Stock Screener›Medi Caps

Medi Caps Share Price Today | Stock Price & Medi Caps Share Screener

MEDICAPQ Pharmaceuticals & Biotechnology
Live Share Price NSE
₹22.94
▲ 0.96 (4.37%)
2026-11-19 00:00:00
Live Share Price BSE
₹21.66
▼ -0.84 (-3.73%)
2026-11-19 00:00:00

As of November 19, 2026, the live Medi Caps share price (NSE: MEDICAPQ) is ₹22.94 on NSE and ₹21.66 on BSE, up 4.37% from the previous close, with shares trading between ₹21.50 and ₹23.06 in today's trading session, and a 52-week range of ₹20.91–₹35.22. Track Medi Caps marketcap in USD to gauge the company's total market size. Use the Medi Caps stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Medi Caps opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹9 and net income of ₹3, with EBITDA of ₹4, an operating margin of -61.0% and a profit margin of 33.3%.

Medi Caps Market Cap ₹29.55 Cr.
MEDICAPQ P/E Ratio (TTM) -551.30
Medi Caps P/B Ratio 0.25
EPS (TTM) ₹-2.44
Dividend Yield -
Debt to Equity -
MEDICAPQ 52 Week High ₹35.22
Medi Caps 52 Week Low ₹20.91
Operating Margin -61.00%
Profit Margin 33.33%
MEDICAPQ Revenue (TTM) ₹9.00
EBITDA ₹4.00
Net Income ₹3.00
Total Assets ₹116.00
Total Equity ₹112.00

Medi Caps Share Price Chart

Track the current stock price of Medi Caps with an interactive chart. Analyse MEDICAPQ share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Medi Caps stock quote in one place.

The quote of ₹22.94 sits between the 52-week low of ₹20.91 and the 52-week high of ₹35.22, and the latest session moved 4.37% from the previous close.

Medi Caps Company Profile - Fundamental Screener

Screen Medi Caps company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDICAPQ shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE442D01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE442D01010

Medi Caps Balance Sheet Screener

Screen MEDICAPQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹116, down from ₹125 in 2025.

Latest statistics put total assets at ₹116 and shareholder funds at ₹112.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 116 125 127 126 130 115 95 107 101 97
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 56 57 59 59 59 58 57 60 61 62

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 1 1 1 1 1 2 2 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 112 121 121 119 116 105 91 96 90 89
Share Capital 13 13 13 13 13 13 13 13 13 13
Reserves & Surplus 99 109 109 106 104 92 79 83 78 77

Medi Caps Income Statement Screener - Profit & Revenue Analysis

Screen Medi Caps income statement and profit fundamentals. Analyze MEDICAPQ quarterly results. Medi Caps reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹9 and net profit was ₹3, equal to earnings per unit of ₹2.44, at an operating margin of -61%.

In that period expenses were ₹6, interest cost ₹0 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹3 and net profit of ₹-2.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 9 3 6 9 3 4 5 8 6 9 4 10 6 6 7
Expenses 6 5 5 7 6 5 5 8 7 8 6 10 7 6 6

Operating Costs and Margins

EBITDA 4 -2 0 2 -3 -1 0 -1 0 1 -2 1 -1 1 1
Operating Profit % -61.00% -70.00% 5.00% -4.00% -126.00% -145.00% -25.00% -13.00% -5.00% 5.00% -45.00% 4.00% -14.00% 8.00% 8.00%
Depreciation 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 3 -2 0 2 -4 -2 -1 -1 -1 0 -2 1 -1 0 0
Tax 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1
Net Profit 3 -2 0 2 -4 -2 -1 -1 -1 0 -2 0 -1 0 0
EPS 2.44 -1.79 -0.07 1.38 -2.80 -1.46 -0.61 -0.86 -0.45 0.25 -1.64 -0.31 -0.89 0.09 -0.13

Medi Caps Cash Flow Screener - Liquidity Fundamentals

Screen MEDICAPQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹7.

Over the same period, investing activities provided ₹7 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -7 5 7 -6 7 15 5 6 4 4
Investing Activities 7 -5 -8 -3 -4 -10 -6 -6 -4 3

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 -6
Net Cash Flow 0 0 -1 -9 3 6 -1 0 0 1

Medi Caps Shareholding Pattern Screener

See Medi Caps shareholding pattern with promoter, FII, and DII holdings. Check Medi Caps promoter holding and ownership changes for MEDICAPQ on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 51.36%, foreign institutions 0.00%, domestic institutions 0.02% and the public 43.93%, spread across 10,349 shareholders.

The shareholder count was 10,349 in 2026-Mar, compared with 10,209 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 51.36% 51.44% 51.44% 50.77% 50.77% 50.77% 50.76% 50.13%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.02% 0.02% 0.02% 0.03% 0.03% 0.03% 0.02% 0.03%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 43.93% 43.76% 43.88% 44.57% 44.34% 44.31% 44.43% 44.83%
Other Holding 4.68% 4.78% 4.65% 4.63% 4.86% 4.89% 4.79% 5.01%
Shareholder Count 10,349 10,209 10,369 11,033 10,851 10,692 10,493 12,356

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Medi Caps. Medi Caps dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Medi Caps.

Medi Caps Stock Index Membership - Nifty & Sensex

See which indices include Medi Caps stock. Check MEDICAPQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Medi Caps is not part of any tracked indices.
Only major market indices are tracked in our system.

Medi Caps Market Events Screener - Corporate Actions

Get Medi Caps corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Medi Caps stock events that may affect MEDICAPQ share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.

It is followed by Annual General Meeting dated September 22, 2026 and Quarterly Result Announcement dated August 6, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-04 2026-11-04 Quarterly Result Announcement NA -0.17%
2026-09-22 2026-09-22 Annual General Meeting NA -3.10%
2026-08-06 2026-08-06 Quarterly Result Announcement NA 2.26%
2026-05-21 2026-05-21 Quarterly Result Announcement NA -6.05%
2026-02-11 2026-02-11 Quarterly Result Announcement NA -3.93%
2025-11-12 2025-11-12 Quarterly Result Announcement NA 0.19%
2025-09-18 2025-09-18 Annual General Meeting NA -10.05%
2025-08-05 2025-08-05 Quarterly Result Announcement NA 2.40%
2025-05-21 2025-05-21 Quarterly Result Announcement NA 0.87%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -5.40%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -6.24%
2024-09-26 2024-09-26 Annual General Meeting NA 4.08%

Medi Caps Competitors Screener - Peer Stocks Comparison

Screen MEDICAPQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

Medi Caps Company Announcements - News & Reports Screener

Screen MEDICAPQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 11, 2026.

The next most recent announcements are dated November 4, 2026 and November 4, 2026.

Date Update Actions
2026-11-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-04 Submission Of Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2026 -
2026-11-04 Board Meeting Outcome for Submission Of Unaudited Standalone & Consolidated Financial Result For The Quarter And Half Year Ended 30.09.2026 -
2026-10-28 Board Meeting Intimation for (Serial No. 03/2026-27) Of The Company Scheduled To Be Held On Wednesday 04Th Day Of November 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-25 Closure of Trading Window -
2026-09-23 Announcements Under Regulation 30(LODR) -
2026-09-23 Voting Results Along With Scrutinizer"S Report Of 43Rd AGM -
2026-09-22 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-25 Information Regarding E-Voting For 43Rd Annual General Meeting. -
2026-08-25 Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants -
2026-08-25 Reg. 34 (1) Annual Report. -
2026-08-25 Submission Of Notice Of Convening 43Rd AGM Of The Company. -
2026-08-19 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-08 Disclosure Under 30(5) Of SEBI (LODR) Regulation 2015 -
2026-08-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-06 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-06 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-06 Announcement under Regulation 30 (LODR)-Change in Management -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹22.94, within a 52-week range of ₹20.91 to ₹35.22. The P/E ratio is -551.30 and the P/B ratio is 0.25, with earnings per unit of ₹-2.44. Market capitalisation stands at ₹29.55 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.